cheaptrix/billsum-US_congress_and_house huggingface dataset:
Federal Government Advertising Equity Accountability Act

To require a report on expenditures for contracts for advertising services, and for other purposes. 1. Short title This Act may be cited as the Federal Government Advertising Equity Accountability Act 2. Report on expenditures for contracts for advertising services (a) In general Section 1105(a) of title 31, United States Code, is amended by adding at the end the following new paragraph: (40) The following information with respect to each executive agency: (A) Expenditures of the executive agency for the prior fiscal year for— (i) all contracts for advertising services; and (ii) contracts for the advertising services of— (I) socially and economically disadvantaged small business concerns (as defined in section 8(a)(4) of the Small Business Act ( 15 U.S.C. 637(a)(4) (II) women- and minority-owned businesses. (B) Estimated expenditures of the executive agency for the fiscal year for which the budget is submitted for— (i) all contracts for advertising services; and (ii) contracts for the advertising services of— (I) socially and economically disadvantaged small business concerns (as defined in section 8(a)(4) of the Small Business Act ( 15 U.S.C. 637(a)(4) (II) women- and minority-owned businesses. . (b) Application date The amendment made by this Act shall apply to the report submitted under section 1105(a) of title 31, United States Code, for fiscal year 2021, and each fiscal year thereafter.

Summary: Federal Government Advertising Equity Accountability Act This bill requires the President to include information in each budget regarding executive agency expenditures for advertising services, including expenditures for the advertising services of socially and economically disadvantaged small businesses and of women and minority-owned businesses.
To authorize the Secretary of the Interior to establish fees for medical services provided in units of the National Park System, and for other purposes.

To authorize the Secretary of the Interior to establish fees for medical services provided in units of the National Park System, and for other purposes. 1. Fees for Medical Services (a) Fees authorized The Secretary may establish and collect fees for medical services provided to persons in units of the National Park System or for medical services provided by National Park Service personnel outside units of the National Park System. (b) National Park Medical Services Fund There is hereby established in the Treasury a fund to be known as the National Park Medical Services Fund (1) donations to the Fund; and (2) fees collected under subsection (a). (c) Availability of amounts All amounts deposited into the Fund shall be available to the Secretary, to the extent provided in advance by Acts of appropriation, for the following in units of the National Park System: (1) Services listed in subsection (a). (2) Preparing needs assessments or other programmatic analyses for medical facilities, equipment, vehicles, and other needs and costs of providing services listed in subsection (a). (3) Developing management plans for medical facilities, equipment, vehicles, and other needs and costs of services listed in subsection (a). (4) Training related to providing services listed in subsection (a). (5) Obtaining or improving medical facilities, equipment, vehicles, and other needs and costs of providing services listed in subsection (a). (d) Definitions For the purposes of this section: (1) Fund The term Fund (2) Secretary The term Secretary

Summary: This bill authorizes the Department of the Interior to establish and collect fees for medical services provided to persons in units of the National Park System or for medical services provided by National Park Service personnel outside system units. The bill establishes the National Park Medical Services Fund, to consist of donations and the fees collected for medical services. The fund shall be available to Interior for (1) providing medical services; (2) preparing needs assessments or analyses for medical facilities, equipment, and vehicles; (3) developing management plans; (4) providing training to furnish medical services; and (5) obtaining or improving medical facilities, equipment, and vehicles.
Modernizing Drug Enforcement Act of 2019

To amend the Controlled Substances Act to deem drugs or other substances that act as mu opioid receptor agonists to be in schedule I, subject to exceptions for substances intended for legitimate medical or research use, and for other purposes. 1. Short title This Act may be cited as the Modernizing Drug Enforcement Act of 2019 2. Drugs or other substances that act as mu opioid receptor agonists (a) Definitions Paragraph (18) of section 102 of the Controlled Substances Act ( 21 U.S.C. 802 (18) (A) The term opiate opioid (i) means any drug or other substance having an addiction-forming or addiction-sustaining liability similar to morphine or being capable of conversion into a drug having such addiction-forming or addiction-sustaining liability; and (ii) includes any drug or other substance that acts as a mu opioid receptor agonist. (B) The term mu opioid receptor (C) The term mu opioid receptor agonist . (b) Scheduling Section 201 of the Controlled Substances Act ( 21 U.S.C. 811 (k) Mu opioid receptor agonists (1) In general Effective as of the date of enactment of the Modernizing Drug Enforcement Act of 2019 (2) Exceptions A chemical substance is exempt from inclusion in schedule I by operation of paragraph (1)— (A) if the substance is the subject of an approved application submitted under subsection (b) or (j) of section 505 of the Federal Food, Drug, and Cosmetic Act; (B) to the extent the substance is exempt from the provisions of section 505 of such Act relating to new drugs because— (i) the substance is intended solely for investigational use as described in section 505(i) of such Act; and (ii) the substance is being used exclusively for purposes of a clinical trial that is the subject of an effective investigational new drug application; or (C) to the extent the substance is the subject of a nonclinical study by researchers qualified by scientific training to investigate the safety and effectiveness of drugs. (3) Listing Not later than 180 days after the date of enactment of the Modernizing Drug Enforcement Act of 2019 .

Summary: Modernizing Drug Enforcement Act of 2019 This bill deems a drug or substance that acts as an opioid mu receptor agonist (e.g., morphine) to be in schedule I of the Controlled Substances Act, subject to certain exceptions. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.
Opioid QuOTA Act

To amend the Controlled Substances Act to require the Attorney General to make procurement quotas for opioid analgesics publicly available, and for other purposes. 1. Short title This Act may be cited as the Opioid Quota Openness, Transparency, and Awareness Act of 2019 Opioid QuOTA Act 2. Public reporting of procurement quotas for opioid analgesics (a) In general Section 306 of the Controlled Substances Act ( 21 U.S.C. 826 (j) (1) In this subsection, the term opioid procurement quota (2) The Attorney General shall make publicly available, including through the Web site of the Drug Enforcement Administration— (A) the quantity of the opioid procurement quota for each registered manufacturer for each year; (B) the quantity of opioid analgesics procured by each registered manufacturer for each year; and (C) except as provided under paragraph (3)— (i) a copy of the form or other application, including any attachments or exhibits, submitted by each registered manufacturer requesting an opioid procurement quota; and (ii) a copy of each year-end or annual report relating to the procurement or use of opioid analgesics submitted to the Attorney General by a registered manufacturer to whom the Attorney General has issued an opioid procurement quota. (3) Upon a request by a registered manufacturer asserting that a document or information described in clause (i) or (ii) of paragraph (2)(C) is exempt from disclosure under section 552(b)(4) of title 5, United States Code, and to the extent that the Attorney General determines that the document or information is exempt from disclosure under such section 552(b)(4), the document or information may be excluded from public disclosure under paragraph (2). . (b) GAO report The Comptroller General of the United States shall submit to Congress a report that, for the 1-year period beginning on the date of enactment of this Act— (1) details— (A) the number of instances in which a registered manufacturer made a request described in section 306(j)(3) of the Controlled Substances Act, as added by subsection (a), with respect to a document or information; and (B) the number of instances in which the Attorney General determined such a document or information was exempt from disclosure under section 552(b)(4) of title 5, United States Code; and (2) evaluates the extent of the independent evaluation conducted by the Attorney General of requests described in section 306(j)(3) of the Controlled Substances Act.

Summary: Opioid Quota Openness, Transparency, and Awareness Act of 2019 or the Opioid QuOTA Act This bill requires the Drug Enforcement Administration to make publicly available on its website certain information regarding opioid procurement quotas. The term "opioid procurement quota" means the maximum quantity of opioid analgesics that a registered manufacturer may procure.
To designate Union Station in Washington, DC, as "Harry S. Truman Union Station".

To designate Union Station in Washington, DC, as Harry S. Truman Union Station 1. Harry S. Truman Union Station (a) Designation Union Station, located at 40 Massachusetts Avenue, NE, Washington, DC, shall be known and designated as Harry S. Truman Union Station (b) References Any reference in a law, map, regulation, document, paper, or other record of the United States to the facility referred to in subsection (a) shall be deemed to be a reference to the Harry S. Truman Union Station

Summary: This bill designates Union Station, located at 40 Massachusetts Avenue, NE, Washington, DC, as the "Harry S. Truman Union Station."
To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.

To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings. 1. Scoring of preventive health savings Section 202 of the Congressional Budget and Impoundment Control Act of 1974 ( 2 U.S.C. 602 (h) Scoring of preventive health savings (1) Determination by the director Upon a request by the chairman or ranking minority member of the Committee on the Budget, the Committee on Finance, or the Committee on Health, Education, Labor, and Pensions of the Senate, or by the chairman or ranking minority member of the Committee on the Budget, the Committee on Energy and Commerce, or the Committee on Ways and Means of the House of Representatives, the Director shall determine if a proposed measure would result in reductions in budget outlays in budgetary outyears through the use of preventive health and preventive health services. (2) Projections If the Director determines that a measure would result in substantial reductions in budget outlays as described in paragraph (1), the Director— (A) shall include, in any projection prepared by the Director, a description and estimate of the reductions in budget outlays in the budgetary outyears and a description of the basis for such conclusions; and (B) may prepare a budget projection that includes some or all of the budgetary outyears, notwithstanding the time periods for projections described in subsection (e) and sections 308, 402, and 424. (3) Definitions As used in this subsection— (A) the term budgetary outyears (B) the term preventive health .

Summary: This bill requires the Congressional Budget Office, upon receiving a request from Congress, to determine if legislation would reduce spending outside of the 10-year budget window through the use of preventive health and preventive health services.
Reef Safe Act of 2019

To require the Commissioner of Food and Drugs to develop standards for a Reef Safe 1. Short title This Act may be cited as the Reef Safe Act of 2019 2. Labeling criteria for reef safe (a) In general As soon as practicable, but not later than 2 years after the date of enactment of this Act, the Secretary, acting through the Commissioner, shall develop labeling criteria for a Reef Safe (b) Reef safe label (1) In general Not later than 2 years after the date of enactment of this Act, the Secretary, acting through the Commissioner, shall develop standards for use of the term Reef Safe 21 U.S.C. 352 (2) Criteria and consultation In developing the standards described in paragraph (1), the Secretary shall— (A) consider the impacts of active sunscreen ingredients on the mortality of, and developmental or reproductive disruptions to, certain marine species, including fish, fish larvae, sea urchins, coral, and shrimp; and (B) consult with appropriate heads of Federal agencies, including the Administrator of the Environmental Protection Agency and the Administrator of the National Oceanic and Atmospheric Administration, with respect to studies on the impacts of active sunscreen ingredients on living components of coral reef ecosystems. (c) Review and revision Not less frequently than once every 10 years, the Secretary, acting through the Commissioner and in consultation with the Administrator of the Environmental Protection Agency and the Administrator of the National Oceanic and Atmospheric Administration, and taking into consideration scientific studies of the Food and Drug Administration, the Environmental Protection Agency, and the National Oceanic and Environmental Protection Agency, shall— (1) review the labeling standards in effect under subsection (b)(1); (2) if appropriate, revise the criteria under subsection (b)(2); and (3) in accordance with such criteria, as revised under paragraph (2) as applicable, update the labeling standards under subsection (b)(1). (d) Definitions In this section— (1) the terms active sunscreen ingredient nonprescription sunscreen 21 U.S.C. 360fff (2) the terms coral coral reef ecosystem 16 U.S.C. 6409 (3) the term Commissioner (4) the term Secretary

Summary: Reef Safe Act of 2019 This bill requires the Food and Drug Administrationto develop labeling criteria and standards for a Reef Safe designation on nonprescription sunscreen.
PFAS Waste Incineration Ban Act of 2019

To prohibit the waste incineration of per- and polyfluoroalkyl substances, and for other purposes. 1. Short title This Act may be cited as the PFAS Waste Incineration Ban Act of 2019 2. Prohibition on waste incineration of PFAS Section 3004 of the Solid Waste Disposal Act ( 42 U.S.C. 6924 (z) PFAS wastes (1) Firefighting foam Not later than 6 months after the date of enactment of this subsection, the Administrator shall promulgate regulations prohibiting the disposal by incineration of firefighting foam containing PFAS, which prohibition shall take effect not later than 9 months after the date of enactment of this subsection. (2) Other PFAS wastes (A) Identification and prohibition Not later than 12 months after the date of enactment of this subsection, the Administrator shall promulgate regulations— (i) identifying additional wastes containing PFAS for which a prohibition on incineration may be necessary to protect human health and the environment; and (ii) prohibiting the disposal by incineration of such identified wastes beginning not later than 18 months after the date of enactment of this subsection. (B) Review and revision The Administrator shall review and revise the list of wastes identified under this paragraph as needed, but not less frequently than every 4 years. (3) Penalties For purposes of section 3008(d), a waste subject to a prohibition under this subsection shall be considered a hazardous waste identified or listed under this subtitle. (4) Definition In this subsection, the term PFAS .

Summary: PFAS Waste Incineration Ban Act of 2019 This bill requires the Environmental Protection Agency (EPA) to promulgate regulations to address the disposal by incineration of perfluoroalkyl or polyfluoroalkyl substances, commonly referred to as PFAS. These substances are man-made and may have adverse human health effects. A variety of products contain the substances, such as nonstick cookware or weatherproof clothing. The EPA must promulgate regulations to prohibit the disposal by incineration of foam that contains PFAS and is used to fight fire. In addition, the EPA must promulgate regulations (1) identifying additional wastes containing PFAS for which a prohibition on incineration may be necessary to protect human health and the environment, and (2) prohibiting such disposal of the identified wastes.
Rural Access to Hospice Act of 2019

To amend title XVIII of the Social Security Act to provide for payments for certain rural health clinic and federally qualified health center services furnished to hospice patients under the Medicare program. 1. Short title This Act may be cited as the Rural Access to Hospice Act of 2019 2. Medicare payment for certain Federally qualified health center and rural health clinic services furnished to hospice patients Section 1834 of the Social Security Act ( 42 U.S.C. 1395m (1) in subsection (o), by adding at the end the following new paragraph: (4) Payment for attending physician services furnished by Federally qualified health centers to hospice patients In the case of services described in section 1812(d)(2)(A)(ii) furnished on or after January 1, 2020, by an attending physician (as defined in section 1861(dd)(3)(B), other than a physician or practitioner who is employed by a hospice program) who is employed by or working under contract with a Federally qualified health center, a Federally qualified health center shall be paid for such services under the prospective payment system under this subsection. ; and (2) by adding at the end the following new subsection: (x) Payment for attending physician services furnished by rural health clinics to hospice patients In the case of services described in section 1812(d)(2)(A)(ii) furnished on or after January 1, 2020, by an attending physician (as defined in section 1861(dd)(3)(B), other than a physician or practitioner who is employed by a hospice program) who is employed by or working under contract with a rural health clinic, a rural health clinic shall be paid for such services under the methodology for all-inclusive rates (established by the Secretary) under section 1833(a)(3), subject to the limits described in section 1833(f). .

Summary: Rural Access to Hospice Act of 2019 This bill allows federally qualified health centers (FQHCs) and rural health centers (RHCs) to receive payment under Medicare for hospice services. Currently, attending physicians who work for FQHCs and RHCs may provide hospice services only outside of FQHC or RHC work hours and must bill Medicare under their own provider numbers; FQHCs and RHCs may not receive payment under Medicare for such services.
Improving Middle Class Access to Higher Education Act

To amend the Higher Education Act of 1965 to increase the income limit of the simplified needs test. 1. Short title This Act may be cited as the Improving Middle Class Access to Higher Education Act 2. Simplified needs test Section 479(b)(1) of the Higher Education Act of 1965 ( 20 U.S.C. 1087ss(b)(1) (1) in subparagraph (A)(ii), by striking $50,000 $100,000 (2) in subparagraph (B)(ii), by striking $50,000 $100,000 3. Effective date The amendments made by this Act shall take effect with respect to award year 2019–2020, and each succeeding award year.

Summary: Improving Middle Class Access to Higher Education Act This bill increases the income limit to qualify for the Free Application for Federal Student Aid Simplified Needs Test from $50,000 to $100,000.
Protecting Communities from New PFAS Act

To amend the Toxic Substances Control Act with respect to manufacturing and processing notices for per- and polyfluoroalkyl substances, and for other purposes. 1. Short title This Act may be cited as the Protecting Communities from New PFAS Act 2. Manufacturing and processing notices for per- and polyfluoroalkyl substances Section 5 of the Toxic Substances Control Act ( 15 U.S.C. 2604 (1) in subsection (h), by adding at the end the following: (7) This subsection does not apply to any chemical substance that is a perfluoroalkyl or polyfluoroalkyl substance. . (2) by adding at the end the following: (j) Per- and polyfluoroalkyl substances (1) Determination Any chemical substance that is a perfluoroalkyl or polyfluoroalkyl substance for which a notice is submitted under subsection (a) shall be deemed to have been determined by the Administrator to present an unreasonable risk of injury to health or the environment under paragraph (3)(A) of such subsection. (2) Order Notwithstanding subsection (a)(3)(A), for a chemical substance described in paragraph (1) of this subsection, the Administrator shall issue an order under subsection (f)(3) to prohibit the manufacture, processing, and distribution in commerce of such chemical substance. .

Summary: Protecting Communities from New PFAS Act This bill requires compliance with certain notification requirements by (1) persons planning to manufacture perfluoroalkyl and polyfluoroalkyl substances (commonly referred to as PFAS) that are not listed on the Environmental Protection Agency (EPA) inventory list, or (2) those planning to manufacture or process PFAS for a significant new use. Under the bill, PFAS may not be exempted from such notification requirements. PFAS are man-made and may have adverse human health effects. A variety of products contain the compounds, such as nonstick cookware or weatherproof clothing. The EPA shall prohibit the manufacture, processing, and distribution of PFAS not listed on the EPA's inventory list or the manufacture or processing of PFAS for a significant new use.
Developing Education by Leveraging Tuition Assistance Act

To amend title 10, United States Code, to allow members of the Armed Forces to use Department of Defense tuition assistance to pay for education or training at lower or lateral degree levels. 1. Short title This Act may be cited as the Developing Education by Leveraging Tuition Assistance Act DELTA Act 2. Payment of tuition for off-duty training or education Section 2007 of title 10, United States Code, is amended— (1) by redesignating subsection (f) as subsection (g); and (2) by inserting after subsection (e) the following new subsection (f): (f) A member of the armed forces may use assistance provided under this section to pay for education or training at a degree level equal to, or lower than, a degree level previously attained by the member if— (1) the education or training is relevant to the professional duties of the member; and (2) the content of the education or training is not substantially similar to the content of other education or training already received by the member. .

Summary: Developing Education by Leveraging Tuition Assistance Act or the DELTA Act This bill allows members of the Armed Forces to use Department of Defense tuition assistance for education or training at a degree level equal to or lower than a level previously attained if (1) it is relevant to the member's professional duties, and (2) the content is not substantially similar to that of education or training previously received.